Back to news

Progressing digital transformation within the NHS

Finding out more about how CLEO Systems operates in the digital health space

Published by CLEO Systems on 28/03/2023

We catch up with David Brown, Managing Director at CLEO Systems talks to us about CLEO Systems’ attendance at two conferences in March 2023:  HETT North 23 and Digital Health Rewired 23


David says: ‘We’ve had a really busy month this March in the digital healthcare arena! Early in the month we exhibited at HETT North which was held at Manchester Central, where the focus was very much on progressing digital transformation within the NHS. This was the first ever regional HETT event to take place, so we were delighted to show support by attending and exhibiting.  We shared some really interesting discussions with other digital healthcare professionals who were interested in finding out more about how CLEO Systems operates in the digital health space.

We were able to share news on our successful First of Type pilot of our CLEO SOLO EPS using FHIR messaging standards at Midlands Partnership NHS Foundation Trust. We launched CLEO SOLO EPS late last year after achieving assurance from NHS Digital for use across outpatient secondary care settings.

There’s such a buzz around the work we’ve done on CLEO SOLO EPS – it’s a gamechanger as it means that patients’ prescriptions can be created and sent electronically to a nominated community pharmacy of the patient’s choice, encouraging sustainability, reducing prescribing errors, reducing clinician time and generally making life easier for clinicians and patients alike. It also reduces associated administration and – as it reduces illegibility - increases safety in prescribing and removes the potential for lost or stolen prescriptions. We’re working hard behind the scenes with other Trust providers to roll out CLEO SOLO EPS elsewhere, and we’re looking forward to sharing our exciting news in coming weeks.

We were also able to share further details on our implementations of CLEO CORE, including the roll out at FCMS CAS centres across Blackpool, Morecombe, Doncaster and Sheffield, it was excellent to see the FCMS team whilst at the show.

We then made our way down south for the start of Digital Health Rewired at the Business Design Centre in Islington. With over 4,000 visitors and a range of stages it was literally ‘the place to be’ for digital healthcare professionals and gave us another opportunity to talk all things electronic prescribing, patient pathways and urgent care!

We had so much interest from visitors about our solutions – there was a great deal of excitement about CLEO SOLO EPS: how people can use it to safely clinically electronically prescribe, and how it can remove medication errors, prescription delays and reduce costs. We had some really engaging conversations about how Trusts and Independent Healthcare providers can use EPS in their outpatient settings, we were really thrilled with the enthusiasm displayed by teams wanting to get EPS up and running in their clinical services in order to enhance patient outcomes. It gives such benefits to patients, and great to see how its instant prescribing capability means patients are quickly able to access prescriptions, rather than having FP10s posted to them or being asked to collect them.

We really enjoyed the talks across the different stages at Digital Health Rewired –  especially such a strong focus on medicines management and digital transformation, topics which featured heavily during the show. It also gives a great voice for digital clinical innovation and interoperability, which is massively important for us here at CLEO Systems.

What was interesting to see was how much things had changed for us at CLEO Systems since we exhibited at Digital Health Rewired in 2022. We are now working across lots of different healthcare settings, from ICBs and ICSs to NHS trusts, from urgent treatment centres to NHS trusts. What hasn’t changed, however, is our commitment to enhancing patient safety with our solutions, which have all been designed in collaboration with clinical experts and all focus on enhancing patient outcomes.

All in all, a really exciting month and we’re looking forward to exhibiting at both shows next year and seeing how far we’ve come since then!